Stay updated with breaking news from Catalyst Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) – Equities research analysts at Zacks Research cut their FY2025 EPS estimates for shares of Catalyst Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 24th. Zacks Research analyst A. Chakroborty now forecasts that the biopharmaceutical company will post earnings per share of $1.51 […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) – Research analysts at HC Wainwright lowered their Q2 2023 earnings estimates for shares of Catalyst Pharmaceuticals in a report released on Friday, May 12th. HC Wainwright analyst A. Fein now forecasts that the biopharmaceutical company will post earnings per share of $0.27 for the quarter, down from […]
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) – Stock analysts at HC Wainwright issued their FY2023 earnings per share estimates for Catalyst Pharmaceuticals in a research note issued on Monday, March 20th. HC Wainwright analyst A. Fein expects that the biopharmaceutical company will post earnings of $1.50 per share for the year. HC Wainwright currently […]
Advisers will vote on whether to recommend replacing the primary Covid-19 vaccine series with the updated bivalent boosters available from Pfizer-BioNTech and Moderna.